Narváez J, Pérez-Vega C, Castro-Bohorquez F J, Garcia-Quintana A M, Biosca M, Vilaseca-Momplet J
Rheumatology Unit, Clínica Delfos, Barcelona, Spain.
Scand J Rheumatol. 2003;32(3):191-5. doi: 10.1080/03009740310002588.
In order to document intestinal pseudo-obstruction (IPO) as a recently recognized manifestation of systemic lupus erythematosus (SLE), we report the case or a woman with SLE who presented with IPO and we review 21 other previously reported cases from an English literature search. In 41% of the cases, IPO was the initial manifestation of their underlying lupus. The clinical and laboratory features were not significantly different from those reported in large series of patients with SLE, except for an apparent association with an urinary tract involvement (ureterohydronephrosis and interstitial cystitis). The pathogenic mechanism of this complication is not fully understood, but seems to be heterogeneous. IPO responded readily to high dose steroid therapy in all patients, but in some cases this complication evolved regardless of the underlying disease activity. A high level of awareness of this complication is needed to avoid unnecessary surgical intervention.
为了将肠道假性梗阻(IPO)记录为系统性红斑狼疮(SLE)最近被认识到的一种表现,我们报告了1例患有IPO的SLE女性病例,并通过检索英文文献回顾了其他21例先前报道的病例。在41%的病例中,IPO是其潜在狼疮的初始表现。临床和实验室特征与大量SLE患者报道的特征无显著差异,只是明显与泌尿系统受累(输尿管肾盂积水和间质性膀胱炎)有关。这种并发症的致病机制尚未完全了解,但似乎是异质性的。所有患者的IPO对高剂量类固醇治疗反应良好,但在某些情况下,无论潜在疾病活动如何,这种并发症都会进展。需要高度认识这种并发症以避免不必要的手术干预。